1T.A.Wynn,Common and unique mechanisms regulate fibrosis in various fibroproliferative diseases[J].J.Clin.Invest.117 (2007):524-529.
2F.Strutz,Potential methods to prevent interstitial fibrosis in renal disease,Expert Opin[J].Investig.Drugs 10 (2001):1 989-2 001.
3T.Sasagawa,K.Suzuki,T.Shiota,T.Kondo,M.Okita,The significance of plasma lysophospholipids inpatients with renal failure on hemodialysis[J].J.Nutr.Sci.Vitaminol.(Tokyo).44(1998):809-818.
4K.Nagatoya,T.Moriyama,N.Kawada,M.Takeji,S.Oseto,T.Murozono,A.Ando,E.Imai,M.Hori,Y-27632 prevents tubulointerstitial fibrosis in mouse kidneys with unilateral ureteral obstruction[J].Kidney Int.61(2002):1 684-1 695.
5M.Zeisberg,J.Hanai,H.Sugimoto,T.Mammoto,D.Charytan,F.Strutz,R.Kalluri,BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury[J].Nat.Med.9(2003):964-968.
